Latest Regulatory Filings News

Tissue Repair Limited reports progress in its Phase 3 clinical trials for TR987® despite enrollment delays caused by US regulatory disruptions, while TR Pro+® sales hit record highs and manufacturing scale-up advances.

Bio-Gene Technology Limited has been awarded two significant grants totaling A$3 million by the US Department of Defense, validating its innovative insecticide technologies Flavocide® and Qcide®. The company is advancing regulatory filings and scaling production to target both military and civilian markets.

Optiscan Imaging Ltd reported a productive December quarter, marked by key product developments, strategic partnerships, and a stronger cash position, setting the stage for growth in medical and veterinary imaging markets.

Opthea Limited has spotlighted Sozinibercept as a potential game-changer in wet age-related macular degeneration (AMD) therapy, presenting compelling clinical data and a clear path to U.S. market entry.

5G Networks Limited has increased its on-market takeover offer for AuCyber Limited from 11 cents to 13.5 cents per share, marking its final bid ahead of the January 30 deadline.

Winsome Resources has taken a significant step forward in developing its Adina Lithium Project by submitting the Preliminary Information Statement to Quebec authorities, initiating a structured permitting process and enhancing stakeholder engagement.